Wolverine Trading
KRYS icon

Wolverine Trading’s Krystal Biotech KRYS Stock Holding History

Wolverine Trading’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$778K Buy
4,400
+1,800
+69% +$269K ﹤0.01% 3175
2025
Q2 		$361K Sell
2,600
-1,900
-42% -$279K ﹤0.01% 3274
2025
Q1 		$828K Buy
4,500
+1,100
+32% +$185K ﹤0.01% 2431
2024
Q4 		$543K Sell
3,400
-1,100
-24% -$195K ﹤0.01% 3306
2024
Q3 		$797K Buy
+4,500
New +$868K ﹤0.01% 2591
2023
Q4 		– Sell
-2,100
Closed -$244K – 4867
2023
Q3 		$244K Hold
2,100
– – ﹤0.01% 3542
2023
Q2 		$243K Buy
+2,100
New +$214K ﹤0.01% 3326
2021
Q3 		– Sell
-3,100
Closed -$214K – 6619
2021
Q2 		$214K Buy
+3,100
New +$216K ﹤0.01% 4929

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's KRYS Position: Q3 2025 in Review

Wolverine Trading opened a new position in Krystal Biotech (KRYS) in Q3 2025: 2,154 shares worth $381K. The stake represents ﹤0.01% of the portfolio and ranks #4037 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in KRYS as recently as Q3 2024.

Wolverine Trading first reported a position in KRYS in Q2 2023 and has held it in 4 quarters since. 284 funds tracked by Wall St. Rank hold KRYS as of Q3 2025.

  • Wolverine Trading held 2,154 shares of Krystal Biotech worth $381K as of Q3 2025.
  • Krystal Biotech was a new Wolverine Trading position in Q3 2025.
  • Krystal Biotech made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4037 holding.
  • Wolverine Trading first reported a position in Krystal Biotech in Q2 2023 and has held it in 4 quarters since.
  • 284 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.